BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease.

Yen Ying Lim; Jason Hassenstab; Carlos Cruchaga; Alison Goate; Anne M. Fagan; Tammie L. S. Benzinger; Paul Maruff; Peter J. Snyder; Colin L. Masters; Ricardo Allegri; Jasmeer Chhatwal; Martin R. Farlow; Neill R. Graff-Radford; Christoph Laske; Johannes Levin; Eric McDade; John M. Ringman; Martin Rossor; Stephen Salloway; Peter R. Schofield; David M. Holtzman; John C. Morris; Randall J. Bateman on behalf of the Dominantly Inherited Alzheimer Network

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease.

More information Original publication

DOI

https://doi.org/10.1093/brain/aww200

Publication Date

2016

Volume

139